Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitals, Public | 2 | 2019 | 58 | 0.690 |
Why?
|
| Safety-net Providers | 1 | 2019 | 55 | 0.640 |
Why?
|
| Health Services Research | 1 | 2019 | 232 | 0.590 |
Why?
|
| Informed Consent | 2 | 2024 | 415 | 0.540 |
Why?
|
| Tuberculosis, Miliary | 1 | 2015 | 14 | 0.500 |
Why?
|
| Tuberculosis, Pleural | 1 | 2015 | 11 | 0.500 |
Why?
|
| PubMed | 1 | 2015 | 32 | 0.490 |
Why?
|
| Acquired Immunodeficiency Syndrome | 5 | 1999 | 367 | 0.480 |
Why?
|
| Antimalarials | 2 | 2012 | 55 | 0.450 |
Why?
|
| Health Status Indicators | 1 | 2014 | 230 | 0.430 |
Why?
|
| Emigration and Immigration | 5 | 2007 | 91 | 0.400 |
Why?
|
| Malaria | 1 | 2012 | 91 | 0.390 |
Why?
|
| Brain Diseases | 3 | 2006 | 411 | 0.380 |
Why?
|
| Disease Outbreaks | 7 | 1996 | 359 | 0.360 |
Why?
|
| Peripheral Nervous System | 1 | 2010 | 51 | 0.350 |
Why?
|
| Public Health | 2 | 2024 | 280 | 0.340 |
Why?
|
| Neurocysticercosis | 2 | 2006 | 27 | 0.340 |
Why?
|
| HIV-1 | 3 | 2010 | 636 | 0.310 |
Why?
|
| HIV Infections | 5 | 2010 | 2154 | 0.300 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 308 | 0.300 |
Why?
|
| Central Nervous System | 1 | 2010 | 450 | 0.300 |
Why?
|
| Developing Countries | 1 | 2010 | 315 | 0.290 |
Why?
|
| Uncompensated Care | 1 | 2007 | 11 | 0.290 |
Why?
|
| Antitubercular Agents | 1 | 2010 | 350 | 0.290 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 515 | 0.260 |
Why?
|
| Social Justice | 1 | 2024 | 56 | 0.230 |
Why?
|
| Malaria, Cerebral | 1 | 2003 | 6 | 0.220 |
Why?
|
| Cysticercosis | 2 | 1994 | 30 | 0.220 |
Why?
|
| Tuberculosis | 1 | 2010 | 613 | 0.220 |
Why?
|
| Malaria, Falciparum | 1 | 2003 | 46 | 0.210 |
Why?
|
| Personal Autonomy | 1 | 2024 | 210 | 0.210 |
Why?
|
| Sarcoma, Kaposi | 2 | 1998 | 190 | 0.210 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 1249 | 0.210 |
Why?
|
| Psychotic Disorders | 1 | 2003 | 146 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2007 | 696 | 0.190 |
Why?
|
| Relief Work | 1 | 2001 | 25 | 0.190 |
Why?
|
| Housing | 1 | 2001 | 67 | 0.190 |
Why?
|
| Disasters | 1 | 2001 | 91 | 0.180 |
Why?
|
| Orbit | 1 | 2001 | 209 | 0.170 |
Why?
|
| Population Surveillance | 4 | 2012 | 631 | 0.170 |
Why?
|
| HIV Seroprevalence | 1 | 1999 | 12 | 0.170 |
Why?
|
| Craniocerebral Trauma | 1 | 2001 | 154 | 0.170 |
Why?
|
| Birth Rate | 1 | 2019 | 15 | 0.170 |
Why?
|
| Private Sector | 1 | 2019 | 31 | 0.170 |
Why?
|
| Utilization Review | 1 | 1999 | 52 | 0.170 |
Why?
|
| Cities | 1 | 2019 | 57 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 929 | 0.160 |
Why?
|
| Geography | 1 | 2019 | 136 | 0.160 |
Why?
|
| Nutritional Status | 1 | 2001 | 350 | 0.160 |
Why?
|
| Liver Abscess, Amebic | 1 | 1998 | 3 | 0.160 |
Why?
|
| Blood Donors | 1 | 1999 | 173 | 0.160 |
Why?
|
| Infant Mortality | 1 | 2019 | 143 | 0.150 |
Why?
|
| Texas | 9 | 2012 | 6445 | 0.150 |
Why?
|
| Delivery of Health Care | 3 | 2019 | 849 | 0.150 |
Why?
|
| Community Health Services | 1 | 1999 | 127 | 0.150 |
Why?
|
| Humans | 38 | 2024 | 270637 | 0.150 |
Why?
|
| Global Health | 2 | 2014 | 672 | 0.140 |
Why?
|
| Mortality | 1 | 2019 | 347 | 0.140 |
Why?
|
| Data Collection | 1 | 2019 | 601 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2019 | 1562 | 0.140 |
Why?
|
| Internationality | 1 | 1996 | 206 | 0.130 |
Why?
|
| Pandemics | 1 | 2024 | 1607 | 0.120 |
Why?
|
| Topography, Medical | 1 | 2014 | 6 | 0.120 |
Why?
|
| Health Policy | 1 | 1996 | 277 | 0.110 |
Why?
|
| Vibrio Infections | 2 | 1983 | 16 | 0.110 |
Why?
|
| Vibrio | 2 | 1983 | 11 | 0.110 |
Why?
|
| Cross-Cultural Comparison | 1 | 2013 | 92 | 0.110 |
Why?
|
| Travel | 2 | 2012 | 191 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 145 | 0.100 |
Why?
|
| Europe | 1 | 2014 | 649 | 0.100 |
Why?
|
| Quality of Life | 1 | 2007 | 4806 | 0.100 |
Why?
|
| Terminology as Topic | 1 | 2015 | 414 | 0.100 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2014 | 127 | 0.100 |
Why?
|
| Campylobacter jejuni | 1 | 1992 | 6 | 0.100 |
Why?
|
| Campylobacter Infections | 1 | 1992 | 42 | 0.100 |
Why?
|
| Clostridium Infections | 2 | 1988 | 263 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 4315 | 0.100 |
Why?
|
| Central America | 3 | 2005 | 28 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2013 | 1076 | 0.090 |
Why?
|
| United States | 4 | 2019 | 15813 | 0.090 |
Why?
|
| Giardiasis | 1 | 1990 | 15 | 0.090 |
Why?
|
| Child Day Care Centers | 1 | 1990 | 28 | 0.090 |
Why?
|
| Seizures | 2 | 1994 | 996 | 0.090 |
Why?
|
| Infant | 2 | 2019 | 13994 | 0.090 |
Why?
|
| Honduras | 2 | 2001 | 15 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 407 | 0.090 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 732 | 0.080 |
Why?
|
| Africa | 2 | 1999 | 128 | 0.080 |
Why?
|
| Typhoid Fever | 2 | 1985 | 22 | 0.080 |
Why?
|
| Male | 19 | 2012 | 128446 | 0.080 |
Why?
|
| Adult | 16 | 2012 | 82023 | 0.070 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 1988 | 109 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2010 | 489 | 0.070 |
Why?
|
| Cytomegalovirus | 1 | 1990 | 494 | 0.070 |
Why?
|
| Female | 18 | 2012 | 148834 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2014 | 878 | 0.070 |
Why?
|
| Middle Aged | 13 | 2012 | 90495 | 0.070 |
Why?
|
| Bacteremia | 1 | 1992 | 722 | 0.060 |
Why?
|
| Mefloquine | 1 | 2003 | 10 | 0.060 |
Why?
|
| Cholera | 1 | 1983 | 24 | 0.060 |
Why?
|
| Foodborne Diseases | 1 | 1983 | 14 | 0.050 |
Why?
|
| Plasmodium falciparum | 1 | 2003 | 68 | 0.050 |
Why?
|
| Adolescent | 7 | 2012 | 32687 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 965 | 0.050 |
Why?
|
| Child | 7 | 2012 | 30558 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2015 | 9450 | 0.050 |
Why?
|
| Sepsis | 1 | 1988 | 673 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2007 | 469 | 0.050 |
Why?
|
| Construction Materials | 1 | 2001 | 6 | 0.050 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 1999 | 189 | 0.040 |
Why?
|
| Syndrome | 1 | 2003 | 1408 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2007 | 901 | 0.040 |
Why?
|
| HIV-2 | 1 | 1999 | 9 | 0.040 |
Why?
|
| Aged | 7 | 2012 | 73579 | 0.040 |
Why?
|
| Animals | 7 | 2010 | 61340 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2001 | 172 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2012 | 17071 | 0.040 |
Why?
|
| Spinal Diseases | 1 | 1999 | 132 | 0.040 |
Why?
|
| El Salvador | 1 | 1997 | 5 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 1998 | 123 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1997 | 47 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 1997 | 99 | 0.040 |
Why?
|
| Homosexuality, Male | 1 | 1997 | 75 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1997 | 296 | 0.040 |
Why?
|
| Civil Rights | 1 | 1996 | 11 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 1999 | 244 | 0.040 |
Why?
|
| Prejudice | 1 | 1996 | 50 | 0.030 |
Why?
|
| Radiography | 1 | 2001 | 1994 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 1997 | 95 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 1997 | 101 | 0.030 |
Why?
|
| Tuberculosis, Meningeal | 1 | 1996 | 35 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2007 | 39954 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 1997 | 314 | 0.030 |
Why?
|
| World Health Organization | 1 | 1996 | 321 | 0.030 |
Why?
|
| Taenia | 1 | 1994 | 13 | 0.030 |
Why?
|
| Odds Ratio | 1 | 1999 | 2297 | 0.030 |
Why?
|
| Praziquantel | 1 | 1994 | 15 | 0.030 |
Why?
|
| Meat | 2 | 1985 | 91 | 0.030 |
Why?
|
| Meat Products | 2 | 1984 | 7 | 0.030 |
Why?
|
| Otitis | 2 | 1983 | 11 | 0.030 |
Why?
|
| Seawater | 2 | 1983 | 16 | 0.030 |
Why?
|
| Ostreidae | 2 | 1983 | 28 | 0.030 |
Why?
|
| Food Microbiology | 2 | 1984 | 34 | 0.030 |
Why?
|
| Young Adult | 1 | 2012 | 22238 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 1996 | 579 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2014 | 199 | 0.030 |
Why?
|
| Poultry Products | 1 | 1992 | 2 | 0.030 |
Why?
|
| Turkeys | 1 | 1992 | 7 | 0.030 |
Why?
|
| Los Angeles | 1 | 1992 | 34 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2007 | 13406 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1998 | 1587 | 0.020 |
Why?
|
| USSR | 1 | 1990 | 6 | 0.020 |
Why?
|
| Risk Factors | 3 | 2005 | 17849 | 0.020 |
Why?
|
| Gastroenteritis | 2 | 1983 | 350 | 0.020 |
Why?
|
| Homosexuality | 1 | 1990 | 30 | 0.020 |
Why?
|
| Zidovudine | 1 | 1990 | 43 | 0.020 |
Why?
|
| Prevalence | 1 | 1997 | 3392 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1990 | 74 | 0.020 |
Why?
|
| Diarrhea | 2 | 1983 | 722 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2001 | 6765 | 0.020 |
Why?
|
| Disease Progression | 1 | 1998 | 6880 | 0.020 |
Why?
|
| Pregnancy | 1 | 1999 | 7916 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1990 | 491 | 0.020 |
Why?
|
| Animal Husbandry | 1 | 2005 | 46 | 0.020 |
Why?
|
| Food Contamination | 1 | 1985 | 27 | 0.020 |
Why?
|
| Mexico | 1 | 2005 | 260 | 0.020 |
Why?
|
| Respirovirus Infections | 1 | 1984 | 29 | 0.020 |
Why?
|
| Botulinum Antitoxin | 1 | 1984 | 3 | 0.010 |
Why?
|
| Botulism | 1 | 1984 | 10 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1985 | 310 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 3840 | 0.010 |
Why?
|
| Neutropenia | 1 | 1988 | 1006 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2005 | 330 | 0.010 |
Why?
|
| Clostridium perfringens | 1 | 1983 | 10 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1998 | 14033 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1999 | 7916 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1992 | 6231 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 1513 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 4837 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1999 | 134 | 0.010 |
Why?
|
| Hospitals, Municipal | 1 | 1996 | 3 | 0.010 |
Why?
|
| Africa South of the Sahara | 1 | 1997 | 111 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 1984 | 701 | 0.010 |
Why?
|
| Prognosis | 2 | 1992 | 22527 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 33840 | 0.010 |
Why?
|
| Time Factors | 2 | 1984 | 12974 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1996 | 2313 | 0.010 |
Why?
|
| Mass Screening | 1 | 1997 | 1547 | 0.000 |
Why?
|
| Incidence | 1 | 1996 | 5814 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1996 | 9278 | 0.000 |
Why?
|
| Homes for the Aged | 1 | 1984 | 25 | 0.000 |
Why?
|
| Salmonella typhi | 1 | 1984 | 20 | 0.000 |
Why?
|
| California | 1 | 1984 | 209 | 0.000 |
Why?
|
| Nursing Homes | 1 | 1984 | 99 | 0.000 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 1984 | 169 | 0.000 |
Why?
|
| Cattle | 1 | 1984 | 818 | 0.000 |
Why?
|
| Feces | 1 | 1984 | 851 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1984 | 1217 | 0.000 |
Why?
|
| Age Factors | 1 | 1984 | 5436 | 0.000 |
Why?
|